1. Acknowledgment of referees

   Acknowledgments Pages: i - i

2. Pharmacology of the potassium channel openers

   • Gillian Edwards
   • Arthur H. Weston

   OriginalPaper Pages: 185 - 193

3. Electrophysiologic effects of potassium channel openers

   • Wilhelm Haverkamp
   • Martin Borggrefe
   • Günter Breithardt

   OriginalPaper Pages: 195 - 202

4. Effects of nicorandil on regional perfusion and left ventricular function

   • M. Schlepper
   • J. Thormann
   • V. Mitrovic

   OriginalPaper Pages: 203 - 211

5. Double-blind comparison of the acute effects of two relevant doses of oral nicorandil on central hemodynamics, left ventricular function, and myocardial contractility

   • Andreas Baumbach
   • Ute Braun
   • Karl R. Karsch

   OriginalPaper Pages: 213 - 220

6. Management of vasospastic angina—Role of nicorandil

   • Juan Carlos Kaski

   OriginalPaper Pages: 221 - 227

7. Potassium channel openers: Clinical applications in ischemic heart disease—Overview of clinical efficacy of nicorandil

   • Charles Knight
   • Henry Purcell
   • Kim Fox

   OriginalPaper Pages: 229 - 236

8. Nicorandil safety in the long-term treatment of coronary heart disease

   • Serge Witchitz
   • Jean-Yves Darmon

   OriginalPaper Pages: 237 - 243

9. Ischemic myocardial cell protection conferred by the opening of ATP-sensitive potassium channels

   • Icilio Cavero
   • Yasmine Djellas
   • Jean-Michel Guillon

   OriginalPaper Pages: 245 - 255

10. Antiischemic effects of nicorandil during coronary angioplasty in humans

    • Satoshi Saito
    • Tsuneo Mizumura
    • Kazushige Sakai

    OriginalPaper Pages: 257 - 263